Many studies about the impact of NAC on TIME in ovarian cancer have been published [11,12,13,35,36,37], and have generally demonstrated that the levels of CD3/CD8 T cells and CD68 tumor-associated macrophages increased after NAC, while Foxp3 regulatory T cells decreased after NAC. Here, FOXP3 is linked to ovarian cancer.